[go: up one dir, main page]

WO1998012910A3 - NOUVEL ISOFORME CREBa - Google Patents

NOUVEL ISOFORME CREBa Download PDF

Info

Publication number
WO1998012910A3
WO1998012910A3 PCT/US1997/017288 US9717288W WO9812910A3 WO 1998012910 A3 WO1998012910 A3 WO 1998012910A3 US 9717288 W US9717288 W US 9717288W WO 9812910 A3 WO9812910 A3 WO 9812910A3
Authority
WO
WIPO (PCT)
Prior art keywords
creba
novel
isoform
polynucleotides
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/017288
Other languages
English (en)
Other versions
WO1998012910A2 (fr
Inventor
Kathleen S Keegan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icos Corp
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Priority to EP97945292A priority Critical patent/EP0876485A2/fr
Priority to JP10515936A priority patent/JP2000505652A/ja
Priority to AU46524/97A priority patent/AU733874B2/en
Publication of WO1998012910A2 publication Critical patent/WO1998012910A2/fr
Publication of WO1998012910A3 publication Critical patent/WO1998012910A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne en général un nouvel isoforme polypeptidique CREBa, des polynucléotides codant le polypeptide, des constructions d'expression comprenant les polynucléotides, une cellule hôte transformée ou transfectée avec les polynucléotides, des procédés de production du polypeptide, et des procédés d'identification d'inhibiteurs de liaison entre le CREBa et d'autres polypeptides ou polynucléotides.
PCT/US1997/017288 1996-09-27 1997-09-26 NOUVEL ISOFORME CREBa Ceased WO1998012910A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP97945292A EP0876485A2 (fr) 1996-09-27 1997-09-26 NOUVEL ISOFORME CREBa
JP10515936A JP2000505652A (ja) 1996-09-27 1997-09-26 新規ＣＲＥＢａイソフォーム
AU46524/97A AU733874B2 (en) 1996-09-27 1997-09-26 Novel CREBa isoform

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/721,684 US5854016A (en) 1996-09-27 1996-09-27 Creba Isoform
US08/721,684 1996-09-27

Publications (2)

Publication Number Publication Date
WO1998012910A2 WO1998012910A2 (fr) 1998-04-02
WO1998012910A3 true WO1998012910A3 (fr) 1998-06-11

Family

ID=24898896

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/017288 Ceased WO1998012910A2 (fr) 1996-09-27 1997-09-26 NOUVEL ISOFORME CREBa

Country Status (7)

Country Link
US (4) US5854016A (fr)
EP (1) EP0876485A2 (fr)
JP (1) JP2000505652A (fr)
CN (1) CN1209840A (fr)
AU (1) AU733874B2 (fr)
CA (1) CA2236154A1 (fr)
WO (1) WO1998012910A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854016A (en) * 1996-09-27 1998-12-29 Icos Corporation Creba Isoform
WO2001029062A2 (fr) * 1999-10-18 2001-04-26 University Technology Corporation Procede de modulation de phenotype cellulaire
US6544746B2 (en) * 2001-08-13 2003-04-08 St. Louis University Rapid and sensitive proximity-based assay for the detection and quantification of DNA binding proteins
US7172865B2 (en) * 2001-08-13 2007-02-06 Saint Louis University Rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
EP2418281B1 (fr) 2003-10-24 2016-06-01 Gencia Corporation Procédés et compositions pour l'administration de polynucléotides
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006104A1 (fr) * 1990-09-28 1992-04-16 The Dana-Farber Cancer Institute Sequences d'adn specifiques aux adipocytes et leur utilisation dans la production d'animaux transgeniques presentant un metabolisme des graisses modifie
US5656452A (en) * 1993-01-15 1997-08-12 President And Fellows Of Harvard College NF-ATp, ' a T lymphocyte DNA-binding protein
US5641486A (en) * 1994-03-18 1997-06-24 Board Of Regents Of The University Of Nebraska Methods for inhibiting transcription of the cyclic AMP responsive element binding protein and the activating transcription factor 1
US5854016A (en) * 1996-09-27 1998-12-29 Icos Corporation Creba Isoform

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BRINDLE, P.K. AND MONTMINY, M.R.: "The CREB family of transcription activators", CURRENT OPINION IN GENETICS AND DEVELOPMENT, vol. 2, no. 2, 1992, pages 199 - 204, XP002056096 *
DATABASE EMBL "me81e12.r1 Soares mouse embryo NbME13.5 14.5 Mus musculus cDNA clone E IMAGE:401998 5', mRNA sequence.", XP002056099, retrieved from EBI *
DE GROOT, R.P. ET AL.: "Multiple and cooperative phosphorylation events regulate the CREM activator function", THE EMBO JOURNAL, vol. 12, no. 10, 1993, pages 3903 - 3911, XP002056627 *
MEINKOTH, J.L. ET AL.: "Induction of a cyclic AMP-responsive gene in living cells requires the nuclear factor CREB", MOLECULAR AND CELLULAR BIOLOGY, vol. 11, 1991, pages 1759 - 1764, XP002056098 *
SHIH, H.-M. ET AL.: "A positive genetic selection for disrupting protein-protein interactions: identification of CREB mutations that prevent association with the coactivator CBP", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 93, no. 24, 16 November 1996 (1996-11-16), pages 13896 - 13901, XP002052728 *
SMOLIK, A.M. ET AL.: "A cyclic AMP-responsive elment-binding transcriptional activator in Drosophila melanogaster, dCREB-A, is a member of the leucine zipper family", MOLECULAR AND CELLULAR BIOLOGY, vol. 12, no. 9, September 1992 (1992-09-01), pages 4123 - 4131, XP002056095 *
The WashU-HHMI Mouse EST Project Unpublished. *

Also Published As

Publication number Publication date
WO1998012910A2 (fr) 1998-04-02
US6248532B1 (en) 2001-06-19
AU733874B2 (en) 2001-05-31
US5959079A (en) 1999-09-28
EP0876485A2 (fr) 1998-11-11
US5854016A (en) 1998-12-29
AU4652497A (en) 1998-04-17
JP2000505652A (ja) 2000-05-16
CN1209840A (zh) 1999-03-03
CA2236154A1 (fr) 1998-04-02
US20020197712A1 (en) 2002-12-26

Similar Documents

Publication Publication Date Title
AU6663294A (en) Cloned dna encoding a udp-galnac:polypeptide,n-acetylgalactos aminyltransferase
IE901696L (en) Fibronectin binding protein as well as its preparation
EP1522584A3 (fr) Sous-unité catalytique p110 delta de phosphatidylinositol 3-kinase
WO2000008057A3 (fr) Molecules designees b7l-1
EP0962467A4 (fr) Anticorps contre les peptides lies a la parathormone humaine
WO1998012328A3 (fr) Polypeptides de bad humaine codant des acides nucleiques et leurs procedes d'utilisation
AU6235294A (en) Methods for producing polypeptide binding sites
WO2000008158A3 (fr) Molecules designees ldcam
EP0825260A3 (fr) Arginase II
WO1999042596A3 (fr) Phosphodiesterase 10
AU3802595A (en) Tripeptidyl aminopeptidase
EP0821064A3 (fr) Fructosyl amino acide oxidase recombinante
WO1998012910A3 (fr) NOUVEL ISOFORME CREBa
AU584930B2 (en) 1-(aminoalkyl)-``,``-diaryl pyrrolidine-, piperidine- and homopiperidine- acetamides and acetonitriles
WO1995034651A3 (fr) Recepteurs du facteur2 liberant la corticotropine
AU2764997A (en) Udp-(n)-acetyl-alpha-d-galactosamine:polypeptide (n)-acetylgalactosaminyltransferase, galnac-t3
WO1998057983A3 (fr) Proteine de mammifere de type facteur de croissance nerveuse
CA2204151A1 (fr) Adn complementaire codant pour un recepteur de type ii de proteines morphogenetiques osseuses (bmp)
WO2000075324A3 (fr) Genes, proteines et matieres de recombinaison de type prion et procedes associes
CA2071950A1 (fr) Proteine fixatrice du collagene et sa preparation
AU1440695A (en) P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
AU1599299A (en) Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators
WO2000031254A3 (fr) Facteur d'induction de l'apoptose
WO1999029720A3 (fr) Proteine 1 mammalienne a helice alpha

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97191785.X

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN CZ FI HU IL JP MX NO PL RU SK

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref document number: 2236154

Country of ref document: CA

Ref document number: 2236154

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1997945292

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1997945292

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997945292

Country of ref document: EP